Schizophrenia Trial, Recruiting NCT04763655 Sponsor: Northwell Health Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT04763655
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You currently experience moderate to severe symptoms such as hallucinations, unusual beliefs, suspicion of others, or disorganized thinking (as measured by a standard rating scale)
  • You have tried at least one antipsychotic medication for at least 6 weeks and it did not work well enough
  • You are able to understand and willing to sign a consent form agreeing to take part
  • If you are a woman, you have a negative pregnancy test and agree to use an accepted form of birth control during the trial
  • You have been diagnosed with schizophrenia, schizoaffective disorder, or schizophreniform disorder

Who may not be able to join:

  • You have a serious neurological condition (such as epilepsy) or a serious hormonal/gland-related condition (confirm with trial site)
  • You have a medical condition that requires you to take medication that affects your mood, thinking, or behaviour
  • You are considered to be at significant risk of harming yourself or others
  • You have significant memory or thinking difficulties, or language barriers that would make it hard to understand and sign the consent form
  • You have any health reasons that would make electroconvulsive therapy (ECT, a treatment using electrical stimulation) unsafe for you
  • You have any health reasons that would make an MRI scan unsafe for you, such as having a pacemaker

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Miklos Argyelan, MD, The Zucker Hillside Hospital

Phone: 718-470-8165

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northwell Health
Registry
ClinicalTrials.gov
Start date
1 April 2020
Est. completion
1 December 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of Response to Brief Psychiatry Rating Scale (BPRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov